154 related articles for article (PubMed ID: 22036986)
1. Lessons from 54 years of pharmaceutical research.
Firestone RA
Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
[No Abstract] [Full Text] [Related]
2. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
3. The lost science of formulation.
Brown MB
Drug Discov Today; 2005 Nov; 10(21):1405-7. PubMed ID: 16243254
[No Abstract] [Full Text] [Related]
4. Pharmaceutical sciences, scientists, and journals--a tribute to pharmaceutical research for its coming of age.
Testa B
Pharm Res; 2005 Feb; 22(2):173-4. PubMed ID: 15783062
[No Abstract] [Full Text] [Related]
5. Drug discovery alliances.
Jones A; Clifford L
Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
[No Abstract] [Full Text] [Related]
6. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
7. Aligning pharmaceutical innovation with medical need.
Nathan C
Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
[No Abstract] [Full Text] [Related]
8. The state of innovation in drug development.
Kola I
Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
[TBL] [Abstract][Full Text] [Related]
9. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
Stegemann S
Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
[TBL] [Abstract][Full Text] [Related]
10. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
11. Decline in economic returns from new drugs raises questions about sustaining innovations.
Berndt ER; Nass D; Kleinrock M; Aitken M
Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
[TBL] [Abstract][Full Text] [Related]
12. The pharmaceutical industry and research in 2002 and beyond.
Dutta AS; Garner A
Drug News Perspect; 2003 Dec; 16(10):637-48. PubMed ID: 14747843
[TBL] [Abstract][Full Text] [Related]
13. Cancer nanotechnology: small, but heading for the big time.
Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
[No Abstract] [Full Text] [Related]
14. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
Grabowski H
Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
[TBL] [Abstract][Full Text] [Related]
15. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
16. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
17. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
18. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
19. The evolving role of collaboration in biotechnology.
Gower JM
Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
[No Abstract] [Full Text] [Related]
20. SOZO--a Euro-Japanese biotechnology conference.
Veryard C
IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
[No Abstract] [Full Text] [Related]
[Next] [New Search]